Latest News

September 19, 2019
Terazosin, a drug used to treat enlarged prostate, may also be able to slow the progression of Parkinson disease.
September 18, 2019
Individuals with HIV are often susceptible to opportunistic pulmonary infections, but the lung lesions resulting from these infections can be mistaken for lung cancer, according to a new study that aimed to characterize features of OPIs versus tumors in patients with HIV.
September 18, 2019
Patients with polycythemia vera and essential thrombocythemia may be able to reduce their symptoms through a low-cost drug used to treat rheumatoid arthritis (RA), according to a new study in British Journal of Haematology.
September 18, 2019
Tennessee has unveiled its proposal to turn the state's Medicaid program into a block grant; the number of abortions across the country have dropped to the lowest levels since the procedure became legal nationwide; New York has temporaily banned the sale of e-cigarettes and nicotine e-liquids.
September 17, 2019
Acute myeloid leukemia is the most common acute adult cancer diagnosed in the United States; 61,000 Americans are living with this disease and more than 10,000 will die of it this year.
September 17, 2019
The importance of sleep is magnified for patients with Alzheimer disease (AD), who commonly experience sleep disturbances due to changes in their neurotransmitter systems. However, the impact of AD and other dementias on sleep is also seen among caregivers of patients with dementia.
September 17, 2019
Sessions and posters from the 35th Congress of the European Committee for Treatment and Research in Multiple Sclerosis discussed various ways to measure patient-reported outcomes in multiple sclerosis.
September 17, 2019
The Health Care Cost Institute (HCCI) Tuesday released their final Healthy Marketplace Index, which also showed that 69% of markets studied showed an increase in concentration.
September 17, 2019
The FDA grants fast track designation of AstraZeneca's dapagliflozin; California to conduct public awareness campaign against vaping; no new US measles cases.
September 17, 2019
Researchers found that post-chemotherapy minimal residual disease (MRD) subtypes were associated with a pattern of failure and time to failure.
Copyright AJMC 2006-2019 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.